Clinical Trial Update: Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy of once-daily Budesonide/Formoterol Turbuhaler 4.5/160 μg for step-down therapy in asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide/Formoterol Turbuhaler 4.5/160 μg (budesonide/formoterol)

Snippet

Sponsor: Hat Yai Medical Education Center | Conditions: Asthma | Phase 3 | Status: COMPLETED